Drug Database
Back to search

Netherlands· NL-74b9627adb6c

Bromfenac Blumont 0,9 mg/ml oogdruppels, oplossing

A bromfenac product containing broomfenac natrium 1,5-water, registered in Netherlands by Blumont Ofta Trading Limited. The same ATC class is registered in 15 of our 19 countries.

ATC S01BC11

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBromfenac Blumont 0,9 mg/ml oogdruppe…ATCS01BC11REGISTER NO.NL-74b9627adb6cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about broomfenac natrium 1,5-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bromfenac is registered in 15 of 19 countries.

Countries holding a registration under ATC S01BC11 (bromfenac), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search bromfenac products by name

Bromfenac · ATC S01BC11

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BROOMFENAC NATRIUM 1,5-WATER
Manufacturer
Blumont Ofta Trading Limited
Country
Netherlands (NL)
ATC code
S01BC11
ATC class
Bromfenac
Defined daily dose
66 mcg, AT
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134072

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

200 interactions on record for bromfenac.

Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bromfenac against other medicinesHow interaction checks work

Bromfenac · interactions on record

200 records

  • 53 severe
  • 145 moderate
  • 2 minor

Most severe, free to view

  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • PrasugrelB01AC22severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromfenac in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromfenac products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Cyprus · Eyebrom
  • Czechia · Bromfenac Olikla
  • Spain · Alcarix, Eyebrom
  • Finland · Bromfenac
  • United Kingdom (Northern Ireland) · Bromfenac Aspire Pharma, Yellox
  • Greece · Eyebrom
  • Iceland · Yellox
  • Italy · Bromoftil, Coxafen
  • Liechtenstein · Yellox
  • Norway · Bromfenac Blumont, Yellox
  • Poland · Brofestill, Bromfenacum Brofestill Krople Do Oczu, Roztwór W Pojemniku Jednodawkowym
  • Portugal · Brovit, Katlox
  • Slovakia · Bromfenac Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a6dbfc62-c9f2-471b-ac48-7aefe550036b
GET /v1/drugs/a6dbfc62-c9f2-471b-ac48-7aefe550036b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134072_smpc.pdf",
  "strength": null,
  "atc_label": "Bromfenac",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134072",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "BOORZUUR (E 284)",
    "BORAX 10-WATER (E 285)",
    "DINATRIUMEDETAAT 2-WATER",
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMSULFIET 0-WATER (E 221)",
    "POVIDON K 30 (E 1201)",
    "TYLOXAPOL",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BROOMFENAC NATRIUM 1,5-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134072.pdf",
  "authorised_at": "2026/07/20",
  "procedure_number": "NL/H/6075/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134072",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bromfenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console